A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test
NCT: NCT07569913 · NOT_YET_RECRUITING
Brief Summary
To evaluate the clinical performance of each analyte (HIV, HBsAg, and Syphilis) on the TruPlex HIV/HepB/Syphilis Rapid Test (TruPlex Test) using capillary blood (fingerstick), EDTA whole blood, EDTA-plasma, and SST-serum samples collected by trained operators at point-of-care settings. Additionally, to evaluate the usability of the TruPlex test through: structured usability assessments, via a questionnaire, completed by trained operators in point-of-care settings.
Frequently Asked Questions
What is A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test?
A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test is a clinical trial registered under NCT07569913. Current status: NOT_YET_RECRUITING.
What is the status of NCT07569913?
The current status of NCT07569913 (A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test) is: NOT_YET_RECRUITING.
When did A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test start?
A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test started on 2026-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.